About us

Our Staff

Angelique Bruyer

Cofounder, President and CEO

Learn more

Angelique Bruyer

Cofounder, President and CEO
Cofounder, President and CEO

Angélique Bruyer, cofounder and CEO of Diag2Tec, holds a Master’s degree in Molecular Biology at Montpellier in France. She brings strong expertise in hematologic cancer biology, built through her work as a research engineer at Montpellier University Hospital and the partner CNRS research team for five years. She combines this scientific background with solid entrepreneurial expertise, reinforced by formal training in business management, enabling her to drive the strategic development of Diag2Tec since ten years.

Jerome Moreaux

Cofounder, CSO

Learn more

Jerome Moreaux

Cofounder, CSO
Cofounder, CSO

Jérôme Moreaux, cofounder and Chief Scientific Officer of Diag2Tec, is Associate Professor of Hematology at the University of Montpellier, CNRS team leader, and Group Leader at Montpellier University Hospital (CHU). Internationally recognized for his expertise, his research focuses on tumorigenesis, epigenetic, genomic instability, and drug resistance in multiple myeloma and B-cell lymphomas to identify novel biomarkers, understand disease progression, and develop precision medicine strategies. Through his academic leadership and translational research, he brings strong scientific direction and innovation to Diag2Tec.

Jean-François Dumas

Cofounder, Financial Strategy

Learn more

Jean-François Dumas

Cofounder, Financial Strategy
Cofounder, Financial Strategy

Jean-François Dumas, Associate of Diag2Tec, is an experienced executive currently serving as Administrative and Financial Director of a major private industrial group. With over 25 years of experience in financial management, strategic planning, and business development, he brings strong expertise in corporate strategy and operations. At Diag2Tec, he co-leads the financial strategy alongside Angélique Bruyer and contributes valuable industrial insight to support the company’s growth and long-term vision.

Jean-Luc Veyrune

Cofounder, Quality process

Learn more

Jean-Luc Veyrune

Cofounder, Quality process
Cofounder, Quality process

Jean-Luc Veyrune, cofounder of Diag2Tec, is a biochemist with over 25 years of experience in hematologic diseases. As a biologist at Montpellier University Hospital, he specializes in quality control of biological samples. At Diag2Tec, he oversees Quality Assurance and regulatory strategy, ensuring compliance and excellence in laboratory operations.

Nicolas Robert

Cofounder, Flow cytometry

Learn more

Nicolas Robert

Cofounder, Flow cytometry
Cofounder, Flow cytometry

Nicolas Robert, Associate of Diag2Tec, has a dual expertise in cancer biology and bioinformatics, with over 15 years of experience at Montpellier University Hospital in minimal residual disease and biomarker detection using flow cytometry. Through research and collaborations, he has developed strong expertise in primary cell culture and functional bioassays. At Diag2Tec, he contributes his scientific and technical expertise to the design of advanced, state-of-the-art preclinical studies.

Alboukadel Kassambara

Cofounder, Bioinformatic Scientist

Learn more

Alboukadel Kassambara

Cofounder, Bioinformatic Scientist
Cofounder, Bioinformatic Scientist

Alboukadel Kassambara, Associate of Diag2Tec, is a computational biologist and data scientist with over 10 years of experience in bioinformatics, biostatistics, and multi-omics data integration. He specializes in translating complex genomic and clinical datasets into actionable insights for biomarker discovery and precision medicine. He has held key roles in academia and industry, notably in computational biology and AI-driven research, and is widely recognized for his contributions to data analysis tools and open-source R packages. At Diag2Tec, he brings strong expertise in bioinformatics and data-driven strategies to support translational research and predictive modeling.